Assoc. Prof. TİMUR TUNCALI

ATLAS Publication Analytics

Articles 15

1. Post-Treatment Persistent Erythrocytosis in Patients with Hodgkin Lymphoma: Molecular Mechanisms Underlying the Pathogenesis of Erythrocytosis.

Koyun D., Yüksel S., Civriz Bozdağ S., Tuncalı T., Kuzu I., Özcan M.

Cancers , vol.18, no.15, 2026 (SCI-Expanded, Scopus)

2. **Innate immunogenetic synergy between KIR and Neanderthal-derived OAS variants predicts COVID-19 outcomes**

Akin H. Y., Tuncali T., Gencer E. B., Cengiz Seval G., Saricaoglu E. M., Gulten E., et al.

PLOS ONE , vol.21, no.5, 2026 (SCI-Expanded, Scopus)

3. Somatic variants and frequencies of familial myeloma germline predisposition genes among patients within the CoMMpass dataset

AKKUŞ E., TUNCALI T., Akin H. Y., Beksaç M.

Expert Review of Hematology , vol.19, no.1, pp.79-88, 2026 (SCI-Expanded, Scopus)

4. Diagnostic Yield and Clinical Utility of Genetic Testing in Turkish Adults with Suspected Inherited Kidney Disease: Insights from a Population with High Parental Consanguinity

KUMRU G., ALTINER Ş., KARAKAYA A., EKİNCİ S., TUNCALI T., KUTLAY N., et al.

Journal of clinical practice and research , 2026 (ESCI, TRDizin)

5. Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the Clinic

Akkus E., TUNCALI T., Beksac M.

Clinical Lymphoma, Myeloma and Leukemia , vol.25, no.6, 2025 (SCI-Expanded, Scopus)

6. A Germline Variant of BNIP1 Gene (rs28199) is Associated with Familial Multiple Myeloma

AKKUŞ E., TUNCALI T., Akin H. Y., SALİHOĞLU A., Sevindik O. G., Kirkizlar H. O., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2024 (SCI-Expanded, Scopus)

7. Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases

AKKUŞ E., TUNCALI T., Akin H. Y., Aydin Y., Besisik S. K., GÜRKAN E., et al.

BRITISH JOURNAL OF HAEMATOLOGY , vol.204, no.3, pp.931-938, 2024 (SCI-Expanded, Scopus)

8. X-linked Dyskeratosis Congenita Case with Mutation 1058C>T(p.Ala353Val) in Dyskerine Gene

ÖKTEM A., KUŞÇU D. D., TUNCALI T., Kahraman U., ÖZBOLAT S.

Indian Journal of Dermatology , vol.69, no.1, pp.106, 2024 (SCI-Expanded, Scopus)

9. Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.

Kiraz A., Sezer O., ALEMDAR A., Canbek S., Duman N., BİŞGİN A., et al.

Journal of medical virology , vol.95, no.2, 2023 (SCI-Expanded, Scopus)

10. **Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS)**

Ili E., Tasdelen E., Durmaz C. D., ALTINER Ş., TUNCALI T., Martinez-Glez V., et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , vol.188, no.6, pp.1792-1800, 2022 (SCI-Expanded, Scopus)

11. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium

DÜNDAR M., FAHRİOGLU U., Yildiz S. H., Bakir-Gungor B., TEMEL Ş. G., AKIN H., et al.

FUNCTIONAL & INTEGRATIVE GENOMICS , vol.22, no.3, pp.291-315, 2022 (SCI-Expanded, Scopus) Sustainable Development

12. Clinical findings in 22q11.2 microdeletion syndrome: case series

ALTINER Ş., TUNCALI T., KUTLAY N., KARABULUT H. G., ILGIN RUHİ H.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.325, 2022 (SCI-Expanded, Scopus)

13. A case report of an atypical FIP1L1-PDGFRA fusion in a patient with hypereosinophilia

EKİNCİ S., CENGİZ SEVAL G., KARABULUT H. G., Vicdan A., YÜKSEL S., KUZU I., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.222, 2022 (SCI-Expanded, Scopus)

14. Evaluation of Plasma Cell Molecular Cytogenetic Findings of Myeloma Patients: One-Year Single-Center Experience

KAPLAN İ., CESUR BALTACI H. N., ALTINER Ş., EKİNCİ S., VİCDAN N. A., KARABULUT H. G., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.413, 2022 (SCI-Expanded, Scopus)

15. ROHMM-A flexible hidden Markov model framework to detect runs of homozygosity from genotyping data

Celik G., TUNCALI T.

HUMAN MUTATION , vol.43, no.2, pp.158-168, 2022 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 6

1. Pnömoniden Genetik Tanıya: ICF Sendromu

alpkıray m. f., İSLAMOĞLU C., ÖZTÜRK A. G., bal s., ERMAN B., TUNCALI T., et al.

31.Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 25 November 2025, pp.100-98, (Full Text)

2. Kronik Lenfositik Lösemi Hastalarında Ighv Somatik Hipermutasyon Profili: Tek Merkez Deneyimi

İLBASMIŞ H., ALTINER Ş., TUNCALI T., KUTLAY N., KARABULUT H. G., EKİNCİ S., et al.

3. Ulusal HematoOnkoGenetik Kongresi, Antalya, Turkey, 27 - 30 October 2025, (Summary Text)

3. Senkopta EKG tekrarının önemi: Uzun QT sendromu olgu sunumu

NAS G. N., ALTINTAŞ M., YILMAZ M. M., RAMOĞLU M. G., HARTUÇ İ., TUNCALI T., et al.

2.Ankara Pediatri Kongresi, Ankara, Turkey, 7 November - 10 March 2024, vol.78, pp.99, (Summary Text)

4. BRCA1 and BRCA2 Germline Sequence Analysis Data: A Single-Center Experience

LEBLEBİCİ C. B., KUTLAY N., ILGIN RUHİ H., TUNCALI T., KARABULUT H. G., EKİNCİ S., et al.

International hereditary cancer congress, Antalya, Turkey, 6 - 09 February 2025, (Summary Text)

5. Could VUS be important in AML?

KUTLAY N., KARABULUT H. G., TUNCALI T., ILGIN RUHİ H., EKİNCİ S., ALTINER Ş., et al.

ESHG Conference Berlin 1-4 June 2024, Berlin, Germany, 01 June 2024, vol.32, pp.923, (Summary Text)

6. Evaluation of the results of cytogenetic, molecular cytogenetic and molecular analysis in non-Hodgkin lymphoma

LEBLEBİCİ C. B., KUTLAY N., VİCDAN N. A., EKİNCİ S., ILGIN RUHİ H., TUNCALI T., et al.

ESHG Conference Berlin 1-4 June 2024, Berlin, Germany, 1 June - 01 April 2024, (Summary Text)

Metrics

Publication

105

Publication (WoS)

Publication (Scopus)

Citation (WoS)

283

H-Index (WoS)

Citation (Scopus)

362

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING

SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS

Publications & Works